HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wilhelm Schänzer Selected Research

metamfepramone

1/2009Doping control analysis of metamfepramone and two major metabolites using liquid chromatography-tandem mass spectrometry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wilhelm Schänzer Research Topics

Disease

12Hypoxia (Hypoxemia)
11/2017 - 10/2008
4Diabetes Mellitus
10/2011 - 03/2006
4Neoplasms (Cancer)
10/2011 - 01/2006
4Osteoporosis
11/2010 - 07/2008
3Breast Neoplasms (Breast Cancer)
08/2018 - 01/2006
3Cachexia
07/2017 - 08/2009
3Sarcopenia
07/2017 - 08/2009
3Type 2 Diabetes Mellitus (MODY)
01/2014 - 01/2005
2Chronic Renal Insufficiency
01/2019 - 01/2012
2Proteinuria
05/2010 - 08/2009
2Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2010 - 04/2009
2Cardiac Arrhythmias (Arrythmia)
08/2009 - 04/2009
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2005 - 01/2005
1Anemia
01/2019
1Muscular Diseases (Myopathy)
01/2018
1Body Weight (Weight, Body)
01/2017
1Muscle Cramp (Cramp)
01/2017
1Hematologic Diseases (Blood Diseases)
11/2016
1beta-Thalassemia (Cooley's Anemia)
11/2016
1Body Remains
11/2015
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
04/2014
1Obesity
01/2014
1Metabolic Diseases (Metabolic Disease)
07/2013
1Chronic Obstructive Pulmonary Disease (COPD)
05/2013
1Inflammation (Inflammations)
01/2013
1Renal Insufficiency (Renal Failure)
07/2012
1Poisoning
01/2012
1Athletic Injuries (Sports Injuries)
11/2011
1Muscular Dystrophies (Muscular Dystrophy)
10/2011
1Dyslipidemias (Dyslipidemia)
04/2010
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
11/2009
1Fatigue
08/2009
1Lung Diseases (Lung Disease)
05/2009
1Asthma (Bronchial Asthma)
05/2009
1Autolysis
02/2009
1Common Cold
01/2009

Drug/Important Bio-Agent (IBA)

9Androgen Receptors (Androgen Receptor)IBA
07/2017 - 07/2008
6Pharmaceutical PreparationsIBA
01/2017 - 08/2009
5Insulin (Novolin)FDA Link
01/2012 - 01/2005
4hematideIBA
12/2014 - 04/2009
3ErythropoietinFDA Link
01/2019 - 04/2009
3Proteins (Proteins, Gene)FDA Link
11/2016 - 08/2009
3Peptides (Polypeptides)IBA
12/2014 - 01/2012
3peginesatideIBA
12/2014 - 01/2012
2Aromatase InhibitorsIBA
08/2018 - 03/2007
2formestaneIBA
08/2018 - 03/2007
2Prolyl-Hydroxylase InhibitorsIBA
11/2017 - 08/2016
2XenonIBA
01/2015 - 07/2014
2SRT2104IBA
01/2014 - 07/2013
2Sirtuin 1IBA
07/2013 - 01/2013
2HematinicsIBA
11/2012 - 01/2012
2GW 501516IBA
04/2010 - 01/2010
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2010 - 04/2009
2PPAR deltaIBA
01/2010 - 04/2009
2Anabolic AgentsIBA
08/2009 - 04/2009
2ClenbuterolIBA
05/2009 - 07/2008
2Insulin Glargine (Lantus)FDA Link
03/2007 - 06/2005
1Performance-Enhancing SubstancesIBA
01/2019
1continuous erythropoietin receptor activatorFDA Link
01/2019
1molidustatIBA
01/2017
1CreatineIBA
01/2017
1Selective Estrogen Receptor Modulators (SERM)IBA
11/2016
1Anabolic Androgenic SteroidsIBA
11/2016
1Plasma SubstitutesIBA
11/2016
1Narcotics (Narcotic Analgesics)IBA
11/2016
1DiureticsIBA
11/2016
1GSK1278863IBA
08/2016
1Oxygen (Dioxygen)IBA
08/2016
1IsotopesIBA
11/2015
1Small Interfering RNA (siRNA)IBA
12/2014
1Insulin-Like PeptidesIBA
12/2014
1AOD 9604IBA
12/2014
1Growth Hormone (Somatotropin)IBA
12/2014
1CobaltIBA
12/2014
1Lisdexamfetamine DimesylateFDA Link
04/2014
1Dopamine (Intropin)FDA LinkGeneric
04/2014
1Norepinephrine (Noradrenaline)FDA LinkGeneric
04/2014
1Amphetamine (Amfetamine)FDA LinkGeneric
04/2014
1ProdrugsIBA
04/2014
1CilomilastIBA
05/2013
1RolipramIBA
05/2013
1RoflumilastIBA
05/2013
1pegylated erythropoietinIBA
07/2012
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2011
1AlbuminsIBA
05/2010
1ProteomeIBA
05/2010
1LipidsIBA
04/2010
1Lipoproteins (Lipoprotein)IBA
04/2010
1CarbohydratesIBA
04/2010
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2010
1Plasminogen Activators (Plasminogen Activator)IBA
11/2009
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2009
1RyanodineIBA
08/2009
1CreatinineIBA
08/2009
1Tocolytic Agents (Tocolytics)IBA
05/2009
1S 40503IBA
04/2009
1Peptide Hydrolases (Proteases)FDA Link
02/2009

Therapy/Procedure

10Therapeutics
01/2018 - 01/2005
1Oral Administration
11/2011
1Investigational Therapies (Experimental Therapy)
10/2011